DIVERSIFIED HEALTHCARE TRUST Segments Disclosure
| For the Year Ended December 31, 2025 | ||||||||||||||||||||
SHOP | Medical Office and Life Science Portfolio | Total | ||||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Rental income | $ | — | $ | 193,809 | $ | 193,809 | ||||||||||||||
| Residents fees and services | 1,312,655 | — | 1,312,655 | |||||||||||||||||
| Total segment revenues | 1,312,655 | 193,809 | 1,506,464 | |||||||||||||||||
| Reconciliation of revenue: | ||||||||||||||||||||
Other revenue (1) | 31,389 | |||||||||||||||||||
| Total revenues | 1,537,853 | |||||||||||||||||||
| Less: | ||||||||||||||||||||
| Senior living labor and benefits | 663,431 | — | 663,431 | |||||||||||||||||
| Dietary | 83,773 | — | 83,773 | |||||||||||||||||
| Utilities | 74,742 | 13,127 | 87,869 | |||||||||||||||||
| Real estate taxes | 45,877 | 22,811 | 68,688 | |||||||||||||||||
| Insurance | 35,071 | 2,185 | 37,256 | |||||||||||||||||
Other operating expenses (2) | 270,505 | 47,556 | 318,061 | |||||||||||||||||
| Interest expense | 18,728 | 9,096 | 27,824 | |||||||||||||||||
| Depreciation and amortization | 189,985 | 62,413 | 252,398 | |||||||||||||||||
Other segment items (3) | 40,543 | 85,254 | 125,797 | |||||||||||||||||
| Segment loss | (110,000) | (48,633) | (158,633) | |||||||||||||||||
| Reconciliation of segment loss: | ||||||||||||||||||||
Other income (1) | 21,602 | |||||||||||||||||||
| General and administrative | (45,502) | |||||||||||||||||||
| Acquisition and certain other transaction related costs | (10,356) | |||||||||||||||||||
| Gain on sale of properties | 99,114 | |||||||||||||||||||
| Interest and other income | 5,839 | |||||||||||||||||||
| Interest expense | (176,674) | |||||||||||||||||||
| Loss on modification or early extinguishment of debt | (42,526) | |||||||||||||||||||
| Income tax expense | (1,743) | |||||||||||||||||||
| Equity in net earnings of an investee | 22,993 | |||||||||||||||||||
| Net loss | $ | (285,886) | ||||||||||||||||||
| For the Year Ended December 31, 2024 | ||||||||||||||||||||
| SHOP | Medical Office and Life Science Portfolio | Total | ||||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Rental income | $ | — | $ | 213,320 | $ | 213,320 | ||||||||||||||
| Residents fees and services | 1,244,389 | — | 1,244,389 | |||||||||||||||||
| Total segment revenues | 1,244,389 | 213,320 | 1,457,709 | |||||||||||||||||
| Reconciliation of revenue: | ||||||||||||||||||||
Other revenue (1) | 37,718 | |||||||||||||||||||
| Total revenues | 1,495,427 | |||||||||||||||||||
| Less: | ||||||||||||||||||||
| Senior living labor and benefits | 630,998 | — | 630,998 | |||||||||||||||||
| Dietary | 85,620 | — | 85,620 | |||||||||||||||||
| Utilities | 70,616 | 13,687 | 84,303 | |||||||||||||||||
| Real estate taxes | 43,624 | 28,483 | 72,107 | |||||||||||||||||
| Insurance | 41,066 | 3,000 | 44,066 | |||||||||||||||||
Other operating expenses (2) | 266,405 | 52,467 | 318,872 | |||||||||||||||||
| Interest expense | 229 | 5,743 | 5,972 | |||||||||||||||||
| Depreciation and amortization | 195,638 | 79,386 | 275,024 | |||||||||||||||||
Other segment items (3) | — | 97,222 | 97,222 | |||||||||||||||||
| Segment loss | (89,807) | (66,668) | (156,475) | |||||||||||||||||
| Reconciliation of segment loss: | ||||||||||||||||||||
Other income (1) | 27,209 | |||||||||||||||||||
| General and administrative | (26,518) | |||||||||||||||||||
| Acquisition and certain other transaction related costs | (2,510) | |||||||||||||||||||
| Interest and other income | 8,950 | |||||||||||||||||||
| Interest expense | (229,267) | |||||||||||||||||||
| Loss on modification or early extinguishment of debt | (324) | |||||||||||||||||||
| Income tax expense | (467) | |||||||||||||||||||
| Equity in net earnings of an investee | 9,147 | |||||||||||||||||||
| Net loss | $ | (370,255) | ||||||||||||||||||
| For the Year Ended December 31, 2023 | ||||||||||||||||||||
| SHOP | Medical Office and Life Science Portfolio | Total | ||||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Rental income | $ | — | $ | 220,530 | $ | 220,530 | ||||||||||||||
| Residents fees and services | 1,151,908 | — | 1,151,908 | |||||||||||||||||
| Total segment revenues | 1,151,908 | 220,530 | 1,372,438 | |||||||||||||||||
| Reconciliation of revenue: | ||||||||||||||||||||
Other revenue (1) | 37,870 | |||||||||||||||||||
| Total revenues | 1,410,308 | |||||||||||||||||||
| Less: | ||||||||||||||||||||
| Senior living labor and benefits | 603,711 | — | 603,711 | |||||||||||||||||
| Dietary | 78,508 | — | 78,508 | |||||||||||||||||
| Utilities | 69,280 | 13,918 | 83,198 | |||||||||||||||||
| Real estate taxes | 44,476 | 29,445 | 73,921 | |||||||||||||||||
| Insurance | 39,572 | 2,854 | 42,426 | |||||||||||||||||
Other operating expenses (2) | 239,544 | 51,747 | 291,291 | |||||||||||||||||
| Interest expense | 551 | 449 | 1,000 | |||||||||||||||||
| Depreciation and amortization | 175,926 | 98,205 | 274,131 | |||||||||||||||||
Other segment items (3) | (40) | 36,095 | 36,055 | |||||||||||||||||
| Segment loss | (99,620) | (12,183) | (111,803) | |||||||||||||||||
| Reconciliation of segment loss: | ||||||||||||||||||||
Other income (1) | 26,822 | |||||||||||||||||||
| General and administrative | (26,131) | |||||||||||||||||||
| Acquisition and certain other transaction related costs | (10,853) | |||||||||||||||||||
| Gains on equity securities, net | 8,126 | |||||||||||||||||||
| Interest and other income | 13,955 | |||||||||||||||||||
| Interest expense | (190,775) | |||||||||||||||||||
| Loss on modification or early extinguishment of debt | (2,468) | |||||||||||||||||||
| Income tax expense | (445) | |||||||||||||||||||
| Net loss | $ | (293,572) | ||||||||||||||||||
| As of December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
Assets (1) | |||||||||||||||||
| SHOP | $ | 2,867,025 | $ | 3,084,101 | $ | 3,134,978 | |||||||||||
| Medical Office and Life Science Portfolio | 1,192,731 | 1,688,034 | 1,866,422 | ||||||||||||||
| All Other | 301,494 | 364,870 | 444,736 | ||||||||||||||
| Total assets | $ | 4,361,250 | $ | 5,137,005 | $ | 5,446,136 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 24, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 26, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Feb 24, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Mar 2, 2020 | |
| 2018 | Mar 1, 2019 | |
| 2017 | Feb 27, 2018 | |
| 2016 | Feb 27, 2017 | |
| 2015 | Feb 24, 2016 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.